Skip to content
STAY UP TO DATE

Latest News

NEWS-Main

All Latest News

Showing 31-37 of 37 articles
Filter by
  • John Fraher, CEO of Adare Pharmaceuticals Named EY Entrepreneur of the Year® 2017 Award Winner in New Jersey

    LAWRENCEVILLE, N.J.–(BUSINESS WIRE)– John Fraher, CEO of Adare Pharmaceuticals, a private global pharmaceutical company, has been named Ernst & Young’s Entrepreneur of the Year in the life sciences category in New Jersey. Fraher led the creation of A... LEARN MORE
  • Adare Pharmaceuticals Celebrates Corporate Headquarters Grand Opening

    Lawrenceville, New Jersey – September 28, 2016 Adare Pharmaceuticals, a private global specialty pharmaceutical company, celebrated the official opening of its Corporate Headquarters located at 1200 Lenox Drive in Lawrenceville, New Jersey. “We are v... LEARN MORE
  • Adare Pharmaceuticals Company Spotlight Presentation at BIO International 2016 Convention

    San Francisco, CA – June 6, 2016 Adare Pharmaceuticals, a global specialty pharmaceutical company, will present its company overview on Tuesday, June 7, at 1:45 PM, in Room 1, at the 2016 BIO International Convention. Hosted by the Biotechnology Indu... LEARN MORE
  • Adare Pharmaceuticals Partners with Cincinnati Children’s on Innovation Fund

    PRINCETON, N.J. & CINCINNATI, OH–(BUSINESS WIRE)– Adare Pharmaceuticals, Inc. and the Cincinnati Children’s Hospital Medical Center today announced that they are partnering together on an Innovation Fund, which will focus on optimizing and reformulat... LEARN MORE
  • Adare Pharmaceuticals Appoints James Jogerst as Vice President, Corporate Development

    PRINCETON, N.J.–(BUSINESS WIRE)–Adare Pharmaceuticals, Inc. announced today that James (Jim) Jogerst has joined the Company as Vice President, Corporate Development. He will be based at the Company’s headquarters in Princeton, NJ. “We are delighted t... LEARN MORE
  • Adare Pharmaceuticals Appoints Joseph Del Buono as Vice President, Finance and Chief Financial Officer

    Princeton, New Jersey – August 26, 2015 Adare Pharmaceuticals, Inc., formerly Aptalis Pharmaceutical Technologies, announced today that Joseph (Joe) Del Buono has joined the Company as Vice President, Finance and Chief Financial Officer. He will be b... LEARN MORE
  • TPG Completes Acquisition of Aptalis Pharmaceutical Technologies summary: Company Renamed Adare Pharmaceuticals

    Bridgewater, NJ & Fort Worth, TX – April 1, 2015 Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed. The company also announced that its new name is A... LEARN MORE